EGFR and glioblastoma: VP has also been shown to suppress expression of YAP/TAZ transcriptional targets (SOX2, C-MYC, and EGFR) in human patient-derived glioblastoma stem cells and confer significant survival benefit in the Drosophila GBM model [70].